About 3 results found for searched term "Lipoprotein (a)" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21301 | Pelacarsen | Others |
| AKCEA-APO(a)-LRx; TQJ230 | ||
| Pelacarsen (AKCEA-APO(a)-LRx) is a liver-specific, antisense oligonucleotide targeting apolipoprotein(a) that reduces lipoprotein(a) by 80% and is well tolerated. | ||
| M40648 | Muvalaplin | Lipoprotein (a) |
| LY3473329 | ||
| Muvalaplin (LY3473329) is a first-in-class, orally active lipoprotein (a) (Lp(a)) inhibitor that inhibits Lp(a) formation by blocking apolipoprotein apo(a)-apo B100 interactions and avoids interaction with the cognate protein fibrinogen. In addition, Muvalaplin is used in the study of cardiovascular and metabolism-related diseases. | ||
| M50915 | apoB (4372-4392) | Others |
| apoB (4372-4392) is a potent lipoprotein(a) assembly inhibitor, with an IC50 of 40 μM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
